-
Signature
-
/s/ James R. Oehler, Attorney-in-Fact
-
Stock symbol
-
HALO
-
Transactions as of
-
Nov 10, 2025
-
Transactions value $
-
-$136,960
-
Form type
-
4
-
Date filed
-
11/12/2025, 05:58 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Connaughton Bernadette |
Director |
C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO |
/s/ James R. Oehler, Attorney-in-Fact |
2025-11-12 |
0001662521 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
HALO |
Common Stock |
Sale |
-$137K |
-2K |
-4.45% |
$68.48 |
43K |
Nov 10, 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: